| [1] |
INGLEZ J C D. Clinical treatment of vascular diseases[M]// NAVARRO T P, DARDIK A, JUNQUEIRA D, et al. Vascular diseases for the non-specialist. Springer, 2017.
|
| [2] |
庄金满, 李选, 李天润, 等. 股浅动脉重建对下肢动脉硬化闭塞症治疗的随机病例对照研究[J]. 北京大学学报(医学版), 2017,49(1): 153-157.
|
| [3] |
LIPATOV K V, PERMYAKOV S V, ASATRYAN A G, et al.Endovascular surgery for critical ischemia of lower extremities with suppurative-necrotic lesion of the feet[J]. Khirurgiia, 2017(9):4-16.
|
| [4] |
DARLING J D, MCCALLUM J C, SODEN P A, et al.Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia[J]. J Vasc Surg, 2017, 66(2): 466-475.
|
| [5] |
王伟民. 通冠胶囊对冠心病经皮冠脉介入术后患者凝血-纤溶系统的影响[J]. 河南医学研究,2017,26(13):2344-2345.
|
| [6] |
GAVRILENKO A V, KOTOV A E, LEPSHOKOV M K.The results of profundoplasty in patients with critical ischemia of lower extremities[J]. Khirurgiia,2017(9):17-22.
|
| [7] |
MORI S, HIRANO K, ITO Y, et al.Clinical outcomes of the intraluminal approach for long occlusive femoropopliteal lesions assessed by intravascular ultrasound[J]. J Atheroscler Thromb, 2017, 24(5):477-486.
|
| [8] |
中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南(上)[J]. 中国血管外科杂志(电子版), 2015, 95(3):145-151.
|
| [9] |
陈忠,杨耀国. 下肢动脉硬化闭塞症腔内治疗进展[J]. 中国普外基础与临床杂志,2018,25(1):3-9.
|
| [10] |
SHANMUGASUNDARAM M, MURUGAPANDIAN S, TRUONG H T, et al.Drug-coated balloon in peripheral artery disease[J]. Cardiovasc Revasc Med, 2019, 20(4):338-343.
|
| [11] |
CASSESE S, NDREPEPA G, LIISTRO F, et al.Drug-coated balloons for revascularization of infrapopliteal arteries: A Meta-analysis of randomized trials[J]. JACC Cardiovasc Interv, 2016, 9(10):1072-1080.
|
| [12] |
孙利坤,王兵. 药物涂层球囊在下肢动脉硬化闭塞性疾病中的应用进展[J]. 实用医学杂志,2017,33(14):2415-2418.
|
| [13] |
CIPOLLARI S, YOKOI H, OHKI T, et al.Long-term effectiveness of the zilver PTX drug-eluting stent for femoropopliteal peripheral artery disease in patients with no patent tibial runoff vessels-results from the zilver PTX Japan post-market surveillance study[J]. J Vasc Interv Radiol, 2018, 29(1):9-17.
|
| [14] |
KRONLAGE M, PRINTZ I, VOGEL B, et al.A comparative study on endovascular treatment of (sub)acute critical limb ischemia: Mechanical thrombectomy vs thrombolysis[J]. Drug Des Devel Ther, 2017,11:1233-1241.
|
| [15] |
SARAIDARIDIS J T, ERGUL E A, CLOUSE W D, et al.The natural history and outcomes of endovascular therapy for claudication[J]. Ann Vasc Surg, 2017, 44:34-40.
|
| [16] |
KOK H K, ASADI H, SHEEHAN M, et al.Outcomes of infrapopliteal angioplasty for limb salvage based on the updated TASC II classification[J]. Diagn Interv Radiol, 2017, 23(5):360-364.
|
| [17] |
SINGH G D, BRINZA E K, HILDEBRAND J, et al.Midterm outcomes after infrapopliteal interventions in patients with critical limb ischemia based on the TASC II classification of below-the-knee arteries[J]. J Endovasc Ther, 2017, 24(3):321-330.
|
| [18] |
贺爽,朱彦. 活血化瘀中药治疗糖尿病外周动脉疾病的研究进展和临床应用前景[J]. 天津中医药,2017,34(3):145-149.
|
| [19] |
ZHOU X, SUN X, GONG X, et al.Astragaloside IV from astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-kB in vivo and in vitro[J]. Int Immunopharmacol, 2017, 42:18-24.
|
| [20] |
CAO Y, HUANG B, GAO C.Salvia miltiorrhiza extract dihydrotanshinone induces apoptosis and inhibits proliferation of glioma cells[J]. Bosn J Basic Med Sci, 2017, 17(3):235-240.
|
| [21] |
高雄一. 益气活血中药对冠心病患者冠脉靶血管干预效果的临床研究[D]. 广州中医药大学, 2017.
|